Abstract
The success of the clinical uses of cisplatin, cis-[PtII(NH 3)2Cl2], has stimulated considerable interest in using other metal complexes as new therapeutic agents. This perspective describes our recent work on several classes of gold(iii), platinum(ii), ruthenium(ii, iii, iv), iron(ii) and vanadium(iv) complexes for anti-cancer and anti-HIV treatments.
| Original language | English |
|---|---|
| Pages (from-to) | 4884-4892 |
| Number of pages | 9 |
| Journal | Dalton Transactions |
| Issue number | 43 |
| DOIs | |
| Publication status | Published - Sept 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Some uses of transition metal complexes as anti-cancer and anti-HIV agents'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver